Reduced body cell mass and functions in lower extremities are associated with mild cognitive impairment and Alzheimer’s dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Reduced body cell mass and functions in lower extremities are associated with mild cognitive impairment and Alzheimer’s dementia ; volume:13 ; number:1 ; day:17 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
Scientific reports ; 13, Heft 1 (17.8.2023), 1-12, 12.2023
- Urheber
-
Doan, Dieu Ni Thi
Kim, Kahye
Ku, Boncho
Lee, Kun Ho
Kim, Jaeuk U.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-39110-9
- URN
-
urn:nbn:de:101:1-2023110413382656646298
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
21.06.2025, 01:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Doan, Dieu Ni Thi
- Kim, Kahye
- Ku, Boncho
- Lee, Kun Ho
- Kim, Jaeuk U.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Dementia / Alzheimer's Disease
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease
Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer’s disease dementia
Language in Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type: Quantitatively or Qualitatively Different?
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer’s dementia: a meta-analysis
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Dementia / Alzheimer's Disease
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease
Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer’s disease dementia
Language in Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type: Quantitatively or Qualitatively Different?
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer’s dementia: a meta-analysis
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Dementia / Alzheimer's Disease
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease
Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer’s disease dementia
Language in Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type: Quantitatively or Qualitatively Different?
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer’s dementia: a meta-analysis
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia